Two Sigma Investments, LP Beam Therapeutics Inc. Transaction History

Two Sigma Investments, LP

$42.8 Billion
Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 369,201 shares of BEAM stock, worth $7.44 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

369,201

Previous 117,088 215.32%

Holding current value

$7.44 Million

Previous $2.9 Million 148.36%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$19.53 - $34.09 $4.92 Million - $8.59 Million	252,113 Added 215.32%	369,201 $7.21 Million
Q4 2024 Feb 14, 2025	BUY	$21.55 - $30.35 $1.08 Million - $1.53 Million	50,271 Added 75.24%	117,088 $2.9 Million
Q3 2024 Nov 14, 2024	SELL	$22.57 - $33.14 $1.22 Million - $1.79 Million	-53,948 Reduced 44.67%	66,817 $1.64 Million
Q2 2024 Aug 14, 2024	SELL	$21.22 - $32.66 $5.05 Million - $7.77 Million	-238,033 Reduced 66.34%	120,765 $2.83 Million
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $8.42 Million - $16.2 Million	358,798 New	358,798 $11.9 Million
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $1.58 Million - $1.94 Million	-53,900 Reduced 87.93%	7,400 $236,000
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $1.85 Million - $2.99 Million	61,300 New	61,300 $1.88 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $6.44 Million - $11.4 Million	161,878 Added 436.12%	198,996 $9.48 Million
Q2 2022 Aug 15, 2022	SELL	$29.86 - $62.36 $969,315 - $2.02 Million	-32,462 Reduced 46.65%	37,118 $1.44 Million
Q1 2022 May 16, 2022	BUY	$53.73 - $82.16 $2.43 Million - $3.71 Million	45,214 Added 185.56%	69,580 $3.99 Million
Q4 2021 Feb 14, 2022	SELL	$68.02 - $99.06 $13 Million - $19 Million	-191,331 Reduced 88.7%	24,366 $1.94 Million
Q3 2021 Nov 15, 2021	BUY	$84.37 - $133.6 $4.06 Million - $6.43 Million	48,096 Added 28.7%	215,697 $18.8 Million
Q2 2021 Aug 16, 2021	BUY	$64.12 - $128.71 $8.56 Million - $17.2 Million	133,525 Added 391.84%	167,601 $21.6 Million
Q1 2021 May 17, 2021	BUY	$71.28 - $120.75 $2.43 Million - $4.11 Million	34,076 New	34,076 $2.73 Million

Others Institutions Holding BEAM

# of Institutions

251

Shares Held

93.9M

Call Options Held

425K

Put Options Held

309K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.42B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Beam Therapeutics Inc. Transaction History